Barclays Reinstated ResMed (RMD) at Underweight

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 1/30/2023

1. TSLA
2. GM
3. CL
4. SOFI
5. SCHW

6. EMN
7. META
8. AMZN
9. SPY
10. CHTR

April 7, 2016 7:32 AM EDT

Price: $222.71 -0.84%

Rating Summary:
12 Buy, 10 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
Up: 18 | Down: 24 | New: 19

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Barclays reinstated coverage on ResMed (NYSE: RMD) with an Underweight rating and a price target of $55.00.

For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.

Shares of ResMed closed at $59.52 yesterday.

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!